Azithromycin
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Animals1
- Cells1
Outcomes
4Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
Azithromycin decreases cellular senescence in human cells.
“Azithromycin preconditioning reduced p53, p21, and CCND1 expression and increased FOXO3A.”
Cellsin CSE-exposed BEAS-2B cells
International journal of chronic obstructive pulmonary disease11 Nov 2025
CCND1
downin mice1
1 study
CCND1
downin mice1
Azithromycin decreases CCND1 in mice.
“Azithromycin treatment lowered SASP secretion and decreased CCND1, p53, and p21 expression, while increasing FOXO3A.”
Animalsin CS-exposed emphysema micelung
International journal of chronic obstructive pulmonary disease11 Nov 2025
FOXO3
upin mice1
1 study
FOXO3
upin mice1
Azithromycin increases FOXO3 in mice.
“Azithromycin treatment lowered SASP secretion and decreased CCND1, p53, and p21 expression, while increasing FOXO3A.”
Animalsin CS-exposed emphysema micelung
International journal of chronic obstructive pulmonary disease11 Nov 2025
Senescence-associated secretory phenotype (SASP)
downin mice1
1 study
Senescence-associated secretory phenotype (SASP)
downin mice1
Azithromycin decreases senescence-associated secretory phenotype (SASP) in mice.
“Azithromycin treatment lowered SASP secretion and decreased CCND1, p53, and p21 expression, while increasing FOXO3A.”
Animalsin CS-exposed emphysema micelung
International journal of chronic obstructive pulmonary disease11 Nov 2025